What are the stocks of traditional Chinese medicine?

Chinese medicine stocks include Yunnan Baiyao, Pien Tze Huang, Baiyun Mountain, Tongrentang, Neptune Bio, Fengyuan Pharmaceutical, Dong 'e Ejiao and Livzon Group.

(1) Yunnan Baiyao: It is a company mainly engaged in chemical raw materials, chemical preparations, Chinese patent medicines, Chinese herbal medicines and biological products. Its circulation market value ranks first in the industry, reaching 8265438+97 million yuan, with a price-earnings ratio of 24.28;

(2) Pien Tze Huang: the leader of traditional Chinese medicine, Pien Tze Huang's quarterly report 202 1 2 shows that the total operating income increased by 2.057% to1847 million yuan, and the net profit increased by 385.4% to 550 million yuan. The prescription of Pien Tze Huang, a leading figure in the field of traditional Chinese medicine, belongs to the top secret formula of the country and is one of the few drugs that allow the use of natural musk. The core products of the company are Pien Tze Huang series, including Pien Tze Huang, Pien Tze Huang capsules, compound Pien Tze Huang ointment and compound Pien Tze Huang buccal tablets. Actively create a strategic pattern of "one core and many products" in pharmaceutical manufacturing. Pien Tze Huang Cosmetics, a subsidiary, has many brands such as Pien Tze Huang and Empress.

(3) Baiyun Mountain: the leader of traditional Chinese medicine. According to the second quarter of 20021,the company's operating income increased by 19.26% to1608 million yuan, and its net profit increased by 50.75% to 875 million yuan. After years of painstaking efforts and accelerated development, the Group has gradually formed four business segments: Da Nan Medicine, Da Health, Da Commerce and Da Medical, and three new formats: e-commerce, capital finance and medical devices.

(4) Tongrentang: the leader of traditional Chinese medicine, Tongrentang's total operating income in the second quarter of 2002/kloc-0 increased by 22.84% year-on-year to 3.653 billion yuan, and its net profit increased by 2.6 1% year-on-year to 306 million yuan. The parent company has more than 500 product approval numbers, and produces more than 200 varieties all the year round, covering 28 product forms such as pills, powders, medicinal liquor, capsules, oral liquid and dropping pills, and has formed a series of cardiovascular and cerebrovascular diseases represented by Angong Niuhuang Pill, Tongren Niuhuang Qingxin Pill and Tongren Dahuoluo Pill. Gynecological series represented by Tongren Wuji Baifeng Pill and Bao Kun Pill, and alcoholic series represented by Guogong Liquor and Guci Xiaotong Liquid, etc. 12 varieties of different series.

(5) Neptune Biology: The company produces about 500 kinds of products, which are divided into four categories: chemical medicine, traditional Chinese medicine, health food and biological medicine, forming a complete product system dominated by anti-tumor products, covering cardiovascular system, respiratory system, digestive system, etc.1/categories (April 8, 20 13, the company

(6) Fengyuan Pharmaceutical Co., Ltd.: The company is the first high-tech enterprise in China to produce cilnidipine, a specific drug for treating hypertension. It has independent intellectual property rights of a number of national first-class and second-class new drug products and has passed the national double-high certification. Mainly engaged in biological drugs, traditional Chinese medicine, chemical synthetic drugs and their preparations.

(7) Dong 'e Ejiao: The company's main business is Chinese medicine industry, and it is the largest Ejiao manufacturer in China. The company's main business is Chinese medicine industry, and it is the largest Ejiao production enterprise in China.

(8) Livzon Group: Shenqi Fuzheng Injection is the exclusive variety of the company, which belongs to the protected variety of traditional Chinese medicine and is listed in the national medical insurance catalogue.

Chinese medicine leading stocks What are the Chinese medicine leading stocks: 1 Pien Tze Huang; ② Yunnan Baiyao; 3 Jiuzhitang; ④ Tong Ren Tang; 5 Baiyun Mountain; 6 Jiang Zhong Pharmaceutical; 7 Ma Yinglong. In addition, Chinese medicine stocks include Neptune Bio, Fengyuan Pharmaceutical, Dong 'e Ejiao and Livzon Group. Since the implementation of the policy of "centralized procurement of the fifth batch of drugs" in the second half of last year, the CSI medicine index has been continuously adjusted back by more than 20%, and it has dropped by-14% in the dimension in the past year, while the CSI Chinese medicine index has been "outstanding", with an increase of nearly 40% in the past year, ranking first in the pharmaceutical sector. 1, Tongrentang (600085): Chinese medicine leading stock. 1October 22nd 10, Tongrentang shares rose 0.6 1% to 33. 1 1 yuan; Within five days, the stock price fell by 1.06%, with a market value of 45.409 billion yuan.

After more than ten years of development, the company has now formed a relatively complete industrial chain with Chinese herbal medicine cultivation, Chinese patent medicine research and development, pharmaceutical logistics and distribution, and pharmaceutical retail as the core.

2. Baiyun Mountain (600332): Chinese medicine leading stock. 654381On October 22nd, the stock price of Baiyun Mountain fell by 0.5% in five days, and the increase since this year has reached 1.7 1%, with the latest price of 29.8 yuan and price-earnings ratio of 16.62.

The company is a Chinese medicine enterprise with the most complete variety, the largest number of Chinese time-honored brands and the largest output value in the domestic Chinese medicine industry. There are more than 400 kinds of traditional Chinese medicines, covering almost all the classifications of traditional Chinese medicines and 45 kinds of national second-class protected traditional Chinese medicines, among which more than 20 kinds are exclusively produced, and more than 0/00 kinds of foreign famous brand pharmaceutical products are exclusively represented. Such as Wang Laoji, Chen Liji, Pan Gaoshou, Jing Xiu Tang, etc. , are well-known century-old stores. Among them, there are 20 exclusive products such as Xiaoke Pill and Huatuo Zaizao Pill. Wang Laoji Herbal Tea, Baoji Pill, Wuji Baifeng Pill and other products are well-known products in South China and Southeast Asia. After five enterprises including Wang Laoji Pharmaceutical and Jingxiutang Pharmaceutical were selected as the first batch of "Chinese Time-honored Brands", three enterprises including Zhong Yi Pharmaceutical were selected as the second batch of "Chinese Time-honored Brands".

3. Pien Tze Huang (600436): Chinese medicine leading stock. 65438+1opening news on October 22nd, Pien Tze Huang recently reported 434.99 yuan, with a turnover of 30 1 10,000 lots, with a total market value of 262.437 billion yuan.

The company was awarded the title of "High-tech Enterprise" by the Ministry of Science and Technology, and passed the re-certification of high-tech enterprises, and was awarded "Top 5 Scientific and Technological Innovation Output of Chinese Medicine Enterprises in China/KLOC-0".

Other Chinese medicine concept stocks include Tianyao Pharmaceutical, Jiudian Pharmaceutical, Erkang Pharmaceutical, Ganyuan Pharmaceutical, Yiling Pharmaceutical, Taiantang Pharmaceutical, Xinbang Pharmaceutical, Jinling Pharmaceutical, Fangsheng Pharmaceutical, Buchang Pharmaceutical, Harbin Pharmaceutical and Magic Pharmaceutical.